REATA REACH Trademark

Trademark Overview

On Tuesday, July 11, 2023, a trademark application was filed for REATA REACH with the United States Patent and Trademark Office. The USPTO has given the REATA REACH trademark a serial number of 98079940. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, July 29, 2024. This trademark is owned by Reata Pharmaceuticals Inc.. The REATA REACH trademark is filed in the Medical & Beauty Services & Agricultural Services, Personal and Legal & Social Services categories with the following description:

Providing patient advocate and support services for patients undergoing medical treatment of neurological, neuromuscular, neuropsychiatric, psychiatric, mitochondrial, ophthalmological, cardiovascular, renal, autoimmune, gastrointestinal, metabolic, seizure, and dermatological diseases and disorders, and epilepsy

Providing information in the field of medical treatment for neurological, neuromuscular, neuropsychiatric, psychiatric, mitochondrial, ophthalmological, cardiovascular, renal, autoimmune, gastrointestinal, metabolic, seizure, and dermatological diseases and disorders, and epilepsy; Consulting services in the field of medical care
reata reach

General Information

Serial Number98079940
Word MarkREATA REACH
Filing DateTuesday, July 11, 2023
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, July 29, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesProviding patient advocate and support services for patients undergoing medical treatment of neurological, neuromuscular, neuropsychiatric, psychiatric, mitochondrial, ophthalmological, cardiovascular, renal, autoimmune, gastrointestinal, metabolic, seizure, and dermatological diseases and disorders, and epilepsy
Goods and ServicesProviding information in the field of medical treatment for neurological, neuromuscular, neuropsychiatric, psychiatric, mitochondrial, ophthalmological, cardiovascular, renal, autoimmune, gastrointestinal, metabolic, seizure, and dermatological diseases and disorders, and epilepsy; Consulting services in the field of medical care

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 10, 2023
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 10, 2023
Primary Code045
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameReata Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIrving, TX 75063

Trademark Events

Event DateEvent Description
Wednesday, March 20, 2024ASSIGNED TO EXAMINER
Monday, April 8, 2024NON-FINAL ACTION WRITTEN
Monday, April 8, 2024NON-FINAL ACTION E-MAILED
Monday, April 8, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 29, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, July 29, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Friday, July 14, 2023NEW APPLICATION ENTERED
Thursday, August 10, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Related Keywords

reach reata medical metabolic gastrointestinal renal cardiovascular autoimmune seizure epilepsy field disorders